TGF-β antagonist attenuates fibrosis but not luminal narrowing in experimental tracheal stenosis.

Repositorio Dspace/Manakin

TGF-β antagonist attenuates fibrosis but not luminal narrowing in experimental tracheal stenosis.

Mostrar el registro completo del ítem

Título: TGF-β antagonist attenuates fibrosis but not luminal narrowing in experimental tracheal stenosis.
Autor: Antón-Pacheco, Juan L.; Usategui, Alicia; Martínez, Iván; García-Herrero, Carmen M.; Gamez, Antonio P.; Grau, Montserrat; Martínez Relimpio, Ana Mª; Rodríguez-Peralto, José L.; Pablos, José L.
Resumen: Introduction/Objective: Acquired tracheal stenosis (ATS) is an unusual disease often secondary to prolonged mechanical trauma. ATS pathogenesis involves inflammation and subsequent fibrosis with narrowing of the tracheal lumen. TGF-β represents a pivotal factor in most fibrotic processes and therefore, a potential target in this context. The aim of this study is to analyze the role of TGF-β as a target for anti-fibrotic interventions in tracheal stenosis. Methods: Human stenotic tracheobronchial tissues from patients with benign airway stenosis and normal controls from pneumonectomy specimens were analyzed. Tracheal stenosis was induced in adult NZ rabbits by a circumferential thermal injury to the mucosa during open surgery and re-anastomosis. Rabbits were treated postoperatively with a peritracheal collagen sponge containing a TGF-β peptide antagonist (p17) or vehicle. Fibrosis was determined by Masson’s trichrome staining, and α-SMA+ Results: Human and rabbit stenotic tissues showed extensive submucosal fibrosis, characterized by significantly increased α-SMA myofibroblasts, CTGF and p-Smad2/3 expression by immunohistochemistry. + myofibroblasts and CTGF expression. In human stenotic lesions, increased p-Smad2/3+ nuclei were also observed. p17 treatment significantly reduced the fibrotic thickness as well as the density of α-SMA+ myofibroblasts and CTGF+ Conclusion: ATS is characterized by a TGF-β dependent fibrotic process but reduction of the fibrotic component by TGF-β1 antagonist therapy was not sufficient to improve tracheal narrowing, suggesting that fibrosis may not be the main contributor to luminal stenosis. cells in rabbit stenotic lesions but failed to improve the luminal area.
Identificador universal: http://hdl.handle.net/10641/1248
Fecha: 2016


Ficheros en el ítem

Ficheros Tamaño Formato Ver
Ana Relimpio.pdf 1.269Mb PDF Ver/Abrir

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro completo del ítem

Atribución-NoComercial-SinDerivadas 3.0 España Excepto si se señala otra cosa, la licencia del ítem se describe comoAtribución-NoComercial-SinDerivadas 3.0 España

Buscar en DSpace


Búsqueda avanzada

Listar

Mi cuenta

Estadísticas

Enlaces